EMPIRI was accepted to participate in the NIH AAP. The program aims to assist small businesses to prepare for Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The AAP will provide mentorship, application assistance and review. This is an exciting opportunity for Empiri that takes us one step closer to our goal of excelling as a small business.
San Francisco, CA, Jan 8, 2023– EMPIRI today announced that it is presenting at Biotech Showcase™ 2023. This year, registered attendees can view EMPIRI’s presentation live, and also access a recorded
At the 11th annual Texas Life Science Forum, held on November 8, 2022, EMPIRI Inc. was once again recognized as one of the Rice Alliance Most Promising Life Science Companies for our E-Slice technolog
EMPIRI scientist Thomas Gallup presents his poster "Single Cell RNA-sequencing Analysis from Clinical Trials Needle Biopsy Cores" at the GCC Single Cell Omics on October 26, 2022. GCC, an inter-insti